Syntax Research, Inc.

SEC CIK: 0001999827
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

VKTX holding history

Viking Therapeutics, Inc. in every 13F filed by Syntax Research, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VKTX overview All 13F holders of VKTX Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2024

Holdings of VKTX by Syntax Research, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−200−100.0%	Sold out	Holders
Q2 2025	200	$5.30K	<0.1%	00.0%	Unchanged	Holders
Q1 2025	200	$4.83K	<0.1%	00.0%	Unchanged	Holders
Q4 2024	200	$8.05K	<0.1%	+200	New	Holders